Open-mkt buys · 90d
$80.00M
8 trades · 3 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$80.00M
Insiders on file
7
Daily buy vs sell · 90 days
■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Parry Graham | Chief Scientific Officer | 4 | $0 | $0 | 2026-09-21 |
| Koe Gary S. | Chief Technical Officer | 4 | $0 | $0 | 2026-09-21 |
| Dong Quehuong (Kathy) | President & CEO, Director | 4 | $0 | $0 | 2026-09-21 |
| Stagliano Nancy | Director | 4 | $0 | $0 | 2026-09-21 |
| OrbiMed Capital GP VII LLC | Director, 10% Owner | 10 | $20.00M | $0 | 2026-09-21 |
| GORDON CARL L | Director, 10% Owner | 20 | $40.00M | $0 | 2026-09-21 |
| ORBIMED ADVISORS LLC | Director, 10% Owner | 10 | $20.00M | $0 | 2026-09-21 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Dong Quehuong (Kathy) | President & CEO | C Conversion deriv | 2026-09-21 | 2026-09-21 | 455,484 | — | $0 | 0 | SEC↗ |
| Parry Graham | Chief Scientific Officer | C Conversion deriv | 2026-09-21 | 2026-09-21 | 85,504 | — | $0 | 0 | SEC↗ |
| Stagliano Nancy | Director | C Conversion deriv | 2026-09-21 | 2026-09-21 | 255,635 | — | $0 | 0 | SEC↗ |
| Koe Gary S. | Chief Technical Officer | C Conversion deriv | 2026-09-21 | 2026-09-21 | 63,656 | — | $0 | 0 | SEC↗ |
| OrbiMed Capital GP VII LLC | Director, 10% Owner | C Conversion deriv | 2026-09-21 | 2026-09-23 | 2,002,310 | — | $0 | 0 | SEC↗ |
| OrbiMed Capital GP VII LLC | Director, 10% Owner | C Conversion deriv | 2026-09-21 | 2026-09-23 | 758,279 | — | $0 | 0 | SEC↗ |
| OrbiMed Capital GP VII LLC | Director, 10% Owner | C Conversion deriv | 2026-09-21 | 2026-09-23 | 1,703,314 | — | $0 | 0 | SEC↗ |
| OrbiMed Capital GP VII LLC | Director, 10% Owner | C Conversion deriv | 2026-09-21 | 2026-09-23 | 1,087,934 | — | $0 | 0 | SEC↗ |
| GORDON CARL L | Director, 10% Owner | C Conversion deriv | 2026-09-21 | 2026-09-23 | 1,087,934 | — | $0 | 0 | SEC↗ |
| GORDON CARL L | Director, 10% Owner | C Conversion deriv | 2026-09-21 | 2026-09-23 | 2,002,310 | — | $0 | 0 | SEC↗ |
| GORDON CARL L | Director, 10% Owner | C Conversion deriv | 2026-09-21 | 2026-09-23 | 758,279 | — | $0 | 0 | SEC↗ |
| GORDON CARL L | Director, 10% Owner | C Conversion deriv | 2026-09-21 | 2026-09-23 | 1,703,314 | — | $0 | 0 | SEC↗ |
| Dong Quehuong (Kathy) | President & CEO | C Conversion | 2026-09-21 | 2026-09-21 | 455,484 | — | $0 | 455,484 | SEC↗ |
| Parry Graham | Chief Scientific Officer | C Conversion | 2026-09-21 | 2026-09-21 | 85,504 | — | $0 | 85,504 | SEC↗ |
| Stagliano Nancy | Director | C Conversion | 2026-09-21 | 2026-09-21 | 255,635 | — | $0 | 255,635 | SEC↗ |
| Koe Gary S. | Chief Technical Officer | C Conversion | 2026-09-21 | 2026-09-21 | 63,656 | — | $0 | 63,656 | SEC↗ |
| OrbiMed Capital GP VII LLC | Director, 10% Owner | P Buy | 2026-09-21 | 2026-09-23 | 333,333 | $15.00 | $5.00M | 5,126,891 | SEC↗ |
| OrbiMed Capital GP VII LLC | Director, 10% Owner | C Conversion | 2026-09-21 | 2026-09-23 | 1,087,934 | — | $0 | 3,090,244 | SEC↗ |
| OrbiMed Capital GP VII LLC | Director, 10% Owner | P Buy | 2026-09-21 | 2026-09-23 | 1,000,000 | $15.00 | $15.00M | 1,758,279 | SEC↗ |
| OrbiMed Capital GP VII LLC | Director, 10% Owner | C Conversion | 2026-09-21 | 2026-09-23 | 758,279 | — | $0 | 758,279 | SEC↗ |
| OrbiMed Capital GP VII LLC | Director, 10% Owner | C Conversion | 2026-09-21 | 2026-09-23 | 1,703,314 | — | $0 | 4,793,558 | SEC↗ |
| OrbiMed Capital GP VII LLC | Director, 10% Owner | C Conversion | 2026-09-21 | 2026-09-23 | 2,002,310 | — | $0 | 2,002,310 | SEC↗ |
| GORDON CARL L | Director, 10% Owner | C Conversion | 2026-09-21 | 2026-09-23 | 758,279 | — | $0 | 758,279 | SEC↗ |
| GORDON CARL L | Director, 10% Owner | C Conversion | 2026-09-21 | 2026-09-23 | 2,002,310 | — | $0 | 2,002,310 | SEC↗ |
| GORDON CARL L | Director, 10% Owner | C Conversion | 2026-09-21 | 2026-09-23 | 1,087,934 | — | $0 | 3,090,244 | SEC↗ |
| GORDON CARL L | Director, 10% Owner | P Buy | 2026-09-21 | 2026-09-23 | 1,000,000 | $15.00 | $15.00M | 1,758,279 | SEC↗ |
| GORDON CARL L | Director, 10% Owner | C Conversion | 2026-09-21 | 2026-09-23 | 1,703,314 | — | $0 | 4,793,558 | SEC↗ |
| GORDON CARL L | Director, 10% Owner | P Buy | 2026-09-21 | 2026-09-23 | 333,333 | $15.00 | $5.00M | 5,126,891 | SEC↗ |
| Parry Graham | Chief Scientific Officer | C Conversion deriv | 2026-09-21 | 2026-09-21 | 85,504 | — | — | 0 | SEC↗ |
| Parry Graham | Chief Scientific Officer | C Conversion | 2026-09-21 | 2026-09-21 | 85,504 | — | — | 85,504 | SEC↗ |
| Koe Gary S. | Chief Technical Officer | C Conversion deriv | 2026-09-21 | 2026-09-21 | 63,656 | — | — | 0 | SEC↗ |
| Koe Gary S. | Chief Technical Officer | C Conversion | 2026-09-21 | 2026-09-21 | 63,656 | — | — | 63,656 | SEC↗ |
| Stagliano Nancy | Director | C Conversion deriv | 2026-09-21 | 2026-09-21 | 255,635 | — | — | 0 | SEC↗ |
| Stagliano Nancy | Director | C Conversion | 2026-09-21 | 2026-09-21 | 255,635 | — | — | 255,635 | SEC↗ |
| Dong Quehuong (Kathy) | President & CEO, Director | C Conversion deriv | 2026-09-21 | 2026-09-21 | 455,484 | — | — | 0 | SEC↗ |
| Dong Quehuong (Kathy) | President & CEO, Director | C Conversion | 2026-09-21 | 2026-09-21 | 455,484 | — | — | 455,484 | SEC↗ |
| GORDON CARL L | Director, 10% Owner | C Conversion deriv | 2026-09-21 | 2026-09-23 | 758,279 | — | $0 | 0 | SEC↗ |
| GORDON CARL L | Director, 10% Owner | C Conversion deriv | 2026-09-21 | 2026-09-23 | 1,703,314 | — | $0 | 0 | SEC↗ |
| GORDON CARL L | Director, 10% Owner | C Conversion deriv | 2026-09-21 | 2026-09-23 | 1,087,934 | — | $0 | 0 | SEC↗ |
| GORDON CARL L | Director, 10% Owner | C Conversion deriv | 2026-09-21 | 2026-09-23 | 2,002,310 | — | $0 | 0 | SEC↗ |
| GORDON CARL L | Director, 10% Owner | P Buy | 2026-09-21 | 2026-09-23 | 1,000,000 | $15.00 | $15.00M | 1,758,279 | SEC↗ |
| GORDON CARL L | Director, 10% Owner | C Conversion | 2026-09-21 | 2026-09-23 | 758,279 | — | — | 758,279 | SEC↗ |
| GORDON CARL L | Director, 10% Owner | P Buy | 2026-09-21 | 2026-09-23 | 333,333 | $15.00 | $5.00M | 5,126,891 | SEC↗ |
| GORDON CARL L | Director, 10% Owner | C Conversion | 2026-09-21 | 2026-09-23 | 1,703,314 | — | — | 4,793,558 | SEC↗ |
| GORDON CARL L | Director, 10% Owner | C Conversion | 2026-09-21 | 2026-09-23 | 1,087,934 | — | — | 3,090,244 | SEC↗ |
| GORDON CARL L | Director, 10% Owner | C Conversion | 2026-09-21 | 2026-09-23 | 2,002,310 | — | — | 2,002,310 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | C Conversion deriv | 2026-09-21 | 2026-09-23 | 758,279 | — | $0 | 0 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | C Conversion deriv | 2026-09-21 | 2026-09-23 | 1,703,314 | — | $0 | 0 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | C Conversion deriv | 2026-09-21 | 2026-09-23 | 1,087,934 | — | $0 | 0 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | C Conversion deriv | 2026-09-21 | 2026-09-23 | 2,002,310 | — | $0 | 0 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | P Buy | 2026-09-21 | 2026-09-23 | 1,000,000 | $15.00 | $15.00M | 1,758,279 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | C Conversion | 2026-09-21 | 2026-09-23 | 758,279 | — | — | 758,279 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | P Buy | 2026-09-21 | 2026-09-23 | 333,333 | $15.00 | $5.00M | 5,126,891 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | C Conversion | 2026-09-21 | 2026-09-23 | 1,703,314 | — | — | 4,793,558 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | C Conversion | 2026-09-21 | 2026-09-23 | 1,087,934 | — | — | 3,090,244 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | C Conversion | 2026-09-21 | 2026-09-23 | 2,002,310 | — | — | 2,002,310 | SEC↗ |